• Je něco špatně v tomto záznamu ?

The influence of treatment, age at onset, and metabolic control on height in children and adolescents with type 1 diabetes-A SWEET collaborative study

J. Svensson, A. Schwandt, D. Pacaud, J. Beltrand, NH. Birkebaek, R. Cardona-Hernandez, K. Casteels, S. Castro, V. Cherubini, D. Cody, N. Fisch, D. Hasnani, O. Kordonouri, I. Kosteria, A. Luczay, A. Pundziute-Lyckå, C. Maffeis, B. Piccini, P....

. 2018 ; 19 (8) : 1441-1450. [pub] 20181010

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028270

Grantová podpora
Johnson & Johnson - International

OBJECTIVE: To describe the association between height, demographics, and treatment in youths with type 1 diabetes participating in an international network for pediatric diabetes centers (SWEET). METHODS: Data were collected from 55 centers with documented patients' height. All subjects below 20 years of age, diabetes duration >1 year, and without celiac disease were included. World Health Organization growth charts were used to calculate height and body mass index z-scores. Multiple hierarchic regression models adjusting for known confounders were applied. RESULTS: Data on 22 941 subjects (51.8% male) were analyzed with a median and interquartile range for age 14.8 years (11.2, 17.6), diabetes duration 5.6 years (3.1, 8.9), and height z-score 0.34 (-0.37, 1.03). Children were taller in the youngest age groups: adjusted height z-scores of 0.31 (±0.06) and 0.39 (±0.06), respectively; with shorter diabetes duration (<2 years: 0.36 [±0.06]; 2-<5 years: 0.34 [±0.06]; ≥5 years: 0.21 [±0.06]) and if they were pump users: 0.35 ± 0.05 vs 0.25 ± 0.05 (>three injections/day and 0.19 ± 0.06 [0-3 injections daily]), respectively. High hemoglobin A1c (HbA1c) and low to normal weight were associated with a lower height z-score. Trends were identical in all models except for gender. No gender differences were found except in the final height model where females exhibited higher z-score than males. CONCLUSION: For youths treated at centers offering modern diabetes management, major growth disturbances are virtually eliminated. For children with a young age at onset, high HbA1c, injections, and/or non-intensive diabetes, treatment still requires attention in order to attain normal growth.

1st Department of Paediatrics Semmelweis University Budapest Hungary

Child and Young Department APDP Diabetes Lisbon Portugal

Childrens's Hospital Auf Der Bult Hannover Germany

DECCP Pediatric Clinic CHL Luxembourg Luxembourg Centre Hospitalier de Luxembourg Luxembourg Luxembourg

Department of Endocrinology and Diabetes Our Lady's Children's Hospital Dublin Ireland

Department of Pediatric Aarhus University Hospital Aarhus Denmark

Department of Pediatric and adolescents Copenhagen University Hospital Herlev Denmark

Department of Pediatrics Motol University Hospital Prague Czech Republic

Department of Pediatrics University Hospitals Leuven KULeuven Leuven Belgium Department of Development and Regeneration KULeuven Leuven Belgium

Diabetology Unit Meyer Children's Hospital Florence Italy

Diacare Diabetes Care and Hormone Clinic Ahmedabad India

Division of Diabetes and Endocrinology Alberta Children's Hospital Department of Paediatrics University of Calgary Calgary Canada

Division of Endocrinology and Diabetes Hospital Sant Joan de Déu Barcelona Spain

Division of Endocrinology Metabolism and Diabetes 1st Department of Pediatrics National and Kapodistrian University of Athens Medical School Aghia Sophia Children's Hospital Athens Greece

Division of Pediatric Diabetes Department of Women's and Children's Health Salesi Hospital Ancona Italy

Institute of Epidemiology and Medical Biometry ZIBMT University of Ulm Ulm Germany German Center for Diabetes Research Munich Neuherberg Germany

Non Profit Organisation T1Diams Quatre Bornes Mauritius

Pediatric Diabetes and Metabolic Disorders Unit and Regional Center for Pediatric Diabetes University Hospital University of Verona Verona Italy

Service d'endocrinologie gynécologie et diabètologie pédiatrique Hôpital universiataire Necker Enfants Malades Assistance publique Hôpitaux de Paris Faculté de médecine Paris Descartes Paris France

The Jesse and Sara Lea Shafer Institute of Endocrinology and Diabetes Schneider Children's Medical Center Petach Tikva Israel

The Queen Silvia Childrens Hospital Sahlgrenska University Hospital Gothenburg Sweden

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028270
003      
CZ-PrNML
005      
20190823104049.0
007      
ta
008      
190813s2018 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/pedi.12751 $2 doi
035    __
$a (PubMed)30105887
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Svensson, Jannet $u Department of Pediatric and adolescents, Copenhagen University Hospital, Herlev, Denmark.
245    14
$a The influence of treatment, age at onset, and metabolic control on height in children and adolescents with type 1 diabetes-A SWEET collaborative study / $c J. Svensson, A. Schwandt, D. Pacaud, J. Beltrand, NH. Birkebaek, R. Cardona-Hernandez, K. Casteels, S. Castro, V. Cherubini, D. Cody, N. Fisch, D. Hasnani, O. Kordonouri, I. Kosteria, A. Luczay, A. Pundziute-Lyckå, C. Maffeis, B. Piccini, P. Luxmi, Z. Sumnik, C. de Beaufort,
520    9_
$a OBJECTIVE: To describe the association between height, demographics, and treatment in youths with type 1 diabetes participating in an international network for pediatric diabetes centers (SWEET). METHODS: Data were collected from 55 centers with documented patients' height. All subjects below 20 years of age, diabetes duration >1 year, and without celiac disease were included. World Health Organization growth charts were used to calculate height and body mass index z-scores. Multiple hierarchic regression models adjusting for known confounders were applied. RESULTS: Data on 22 941 subjects (51.8% male) were analyzed with a median and interquartile range for age 14.8 years (11.2, 17.6), diabetes duration 5.6 years (3.1, 8.9), and height z-score 0.34 (-0.37, 1.03). Children were taller in the youngest age groups: adjusted height z-scores of 0.31 (±0.06) and 0.39 (±0.06), respectively; with shorter diabetes duration (<2 years: 0.36 [±0.06]; 2-<5 years: 0.34 [±0.06]; ≥5 years: 0.21 [±0.06]) and if they were pump users: 0.35 ± 0.05 vs 0.25 ± 0.05 (>three injections/day and 0.19 ± 0.06 [0-3 injections daily]), respectively. High hemoglobin A1c (HbA1c) and low to normal weight were associated with a lower height z-score. Trends were identical in all models except for gender. No gender differences were found except in the final height model where females exhibited higher z-score than males. CONCLUSION: For youths treated at centers offering modern diabetes management, major growth disturbances are virtually eliminated. For children with a young age at onset, high HbA1c, injections, and/or non-intensive diabetes, treatment still requires attention in order to attain normal growth.
650    _2
$a mladiství $7 D000293
650    _2
$a věk při počátku nemoci $7 D017668
650    _2
$a krevní glukóza $x účinky léků $x metabolismus $7 D001786
650    12
$a tělesná výška $x účinky léků $x fyziologie $7 D001827
650    _2
$a dítě $7 D002648
650    _2
$a vývoj dítěte $x účinky léků $x fyziologie $7 D002657
650    _2
$a spolupráce organizací a občanů $x organizace a řízení $7 D019058
650    _2
$a kooperační chování $7 D003299
650    _2
$a průřezové studie $7 D003430
650    _2
$a databáze faktografické $7 D016208
650    _2
$a diabetes mellitus 1. typu $x farmakoterapie $x epidemiologie $x metabolismus $7 D003922
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glykovaný hemoglobin $x účinky léků $x metabolismus $7 D006442
650    _2
$a lidé $7 D006801
650    _2
$a inzulin $x aplikace a dávkování $x farmakologie $7 D007328
650    _2
$a inzulinové infuzní systémy $7 D007332
650    _2
$a mezinárodní spolupráce $7 D007391
650    _2
$a mužské pohlaví $7 D008297
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Schwandt, Anke $u Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany. German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.
700    1_
$a Pacaud, Daniele $u Division of Diabetes and Endocrinology, Alberta Children's Hospital, Department of Paediatrics, University of Calgary, Calgary, Canada.
700    1_
$a Beltrand, Jacques $u Service d'endocrinologie, gynécologie et diabètologie pédiatrique, Hôpital universiataire Necker Enfants Malades, Assistance publique Hôpitaux de Paris, Faculté de médecine Paris Descartes, Paris, France.
700    1_
$a Birkebaek, Niels H $u Department of Pediatric, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a Cardona-Hernandez, Roque $u Division of Endocrinology and Diabetes, Hospital Sant Joan de Déu, Barcelona, Spain.
700    1_
$a Casteels, Kristina $u Department of Pediatrics, University Hospitals Leuven, KULeuven, Leuven, Belgium. Department of Development and Regeneration, KULeuven, Leuven, Belgium.
700    1_
$a Castro, Sofia $u Child and Young Department, APDP-Diabetes, Lisbon, Portugal.
700    1_
$a Cherubini, Valentino $u Division of Pediatric Diabetes, Department of Women's and Children's Health, Salesi Hospital, Ancona, Italy.
700    1_
$a Cody, Declan $u Department of Endocrinology and Diabetes, Our Lady's Children's Hospital, Dublin, Ireland.
700    1_
$a Fisch, Naama $u The Jesse and Sara Lea Shafer Institute of Endocrinology and Diabetes, Schneider Children's Medical Center, Petach Tikva, Israel.
700    1_
$a Hasnani, Dhruvi $u Diacare-Diabetes Care and Hormone Clinic, Ahmedabad, India.
700    1_
$a Kordonouri, Olga $u Childrens's Hospital Auf Der Bult, Hannover, Germany.
700    1_
$a Kosteria, Ioanna $u Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, Greece.
700    1_
$a Luczay, Andrea $u Ist Department of Paediatrics, Semmelweis University, Budapest, Hungary.
700    1_
$a Pundziute-Lyckå, Auste $u The Queen Silvia Childrens Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
700    1_
$a Maffeis, Claudio $u Pediatric Diabetes and Metabolic Disorders Unit and Regional Center for Pediatric Diabetes, University Hospital, University of Verona, Verona, Italy.
700    1_
$a Piccini, Barbara $u Diabetology Unit, Meyer Children's Hospital, Florence, Italy.
700    1_
$a Luxmi, Poran $u Non-Profit Organisation T1Diams, Quatre Bornes, Mauritius.
700    1_
$a Sumnik, Zdenek $u Department of Pediatrics, Motol University Hospital, Prague, Czech Republic.
700    1_
$a de Beaufort, Carine $u DECCP, Pediatric Clinic/CHL, Luxembourg, Luxembourg Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
773    0_
$w MED00181048 $t Pediatric diabetes $x 1399-5448 $g Roč. 19, č. 8 (2018), s. 1441-1450
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30105887 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190823104303 $b ABA008
999    __
$a ok $b bmc $g 1433419 $s 1066730
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 19 $c 8 $d 1441-1450 $e 20181010 $i 1399-5448 $m Pediatric diabetes $n Pediatr Diabetes $x MED00181048
GRA    __
$p Johnson &amp; Johnson $2 International
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace